search
Back to results

Exercise Training for Brachial Plexus Injury Following Nerve Transfer

Primary Purpose

Brachial Plexus Injury

Status
Not yet recruiting
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Exercise group
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brachial Plexus Injury

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: adults age 18-60 electrodiagnostically confirmed brachial plexus injury affecting the musculocutaneous nerve able to consent for participation. Exclusion Criteria: • individuals with additional neurological or musculoskeletal conditions that would affect elbow and hand function

Sites / Locations

  • University of Alberta

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Exercise group

Control group

Arm Description

Each participant in the exercise group will undergo hand grip exercise for 30 minutes a day, 5 days a week for a total of 12 weeks. To activate the ulnar nerve innervated muscles, the exercise will be done using an electronic hand grip device with adjustable resistance individualized to the strength of each participant.

Participants will carry out a stretch exercise routine that is not known to have any effect on nerve regeneration.

Outcomes

Primary Outcome Measures

Motor nerve conduction study
compound muscle action potential of the biceps muscle. Range: 0-7 mV. Higher scores signify better nerve regeneration

Secondary Outcome Measures

magnetic resonance imaging (MRI)
muscle bulk of the biceps. Measure in cubic cm. Higher score signifies better nerve regeneration.
dual energy x-rays absorptiometry (DEXA)
bone density - humerus (g/sq. m). Higher scores denote better outcome
quantitative force measurement for elbow flexion using dynamometer DASH Questionnaire
to assess impairment (N). Higher scores denote better outcome
Canadian Occupational Performance Measure (COPM)
to assess handicap and participation (Range 1-5). Higher scores denote better outcome

Full Information

First Posted
April 5, 2023
Last Updated
June 23, 2023
Sponsor
University of Alberta
Collaborators
Royal Alexandra Hospital, Glenrose Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT05859178
Brief Title
Exercise Training for Brachial Plexus Injury Following Nerve Transfer
Official Title
Exercise Training to Improve Nerve Regeneration and Function in Patients With Brachial Plexus Injury Following Nerve Transfer - a Randomized Controlled Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 1, 2023 (Anticipated)
Primary Completion Date
May 31, 2025 (Anticipated)
Study Completion Date
May 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alberta
Collaborators
Royal Alexandra Hospital, Glenrose Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Although peripheral nerve is capable of regrowth following injury, at only 1 mm/day, the slow rate represents a major barrier. Apart from rapid deterioration of the environment supportive of growth, denervated muscles become atrophic and bones osteoporotic. To successfully restore function, in addition to speeding up the nerve regeneration rate, treatments that can also restore muscle and bone mass are essential. Recently, in animal studies, the investigators showed that in addition to accelerating the speed of nerve regeneration, exercise training can also be used to restore muscle bulk and bone density. While promising, given the inter-species differences, the clinical utilities of this treatment need to be directly tested in humans. This will be done using a randomized controlled study design on patients with brachial plexus injury.
Detailed Description
Peripheral nerve injury is common, affecting 3% of patients with limb trauma seen in the emergency department. Of those, young males who are active in the work force are most frequently inflicted. The functional loss does not only carry a huge personal burden but is also associated with substantial healthcare and socioeconomic costs. Indeed, based on data from the National Inpatient Sample in the US, estimated direct healthcare costs for patients who sustained upper limb nerve injury is over $1.2B per year. Although in previous studies the investigators found that conditioning electrical stimulation, a form of activity dependent therapy, enhances nerve regeneration following injury, it did not improve bone density. Therefore, alternative treatments capable of promoting bone formation, restoring muscle bulk and increasing nerve regeneration are needed. Based on recent discoveries in animal studies, the goal of this randomized controlled clinical trial is to test the hypothesis that exercise training can accelerate nerve regeneration and significantly increase muscle bulk and bone density compared to surgery alone in patients with brachial plexus injury. To test this hypothesis, patients with brachial plexus injury involving the musculocutaneous nerve will be randomized to the exercise or control group following nerve transfer surgery. This will be done using a redundant branch of the ulnar nerve to reinnervate the biceps muscle. To evaluate the treatment efficacy, compound muscle action potential of the biceps muscle will be used as the primary outcome measure to quantify reinnervation. The following anatomic and functional measures will be used as secondary outcome measures: i) muscle bulk of the biceps using MRI; ii) bone density of the humerus using dual-energy x-ray absorptiometry (DEXA) imaging; iii) quantitative force measurement for elbow flexion; iv) the Disability of Arm, Shoulder and Hand (DASH) instrument to assess disability, and v) the Canadian Occupational Performance Measure for limitations in participation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brachial Plexus Injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
Participants assigned to the exercise group will perform strengthening exercise. Those assigned to the control group will carry out stretch exercise that is not known to have any effect on nerve regeneration.
Masking
ParticipantOutcomes Assessor
Masking Description
The assessor will not be involved in treatment delivery. Participants in the control group will carry out sham exercise.
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Exercise group
Arm Type
Experimental
Arm Description
Each participant in the exercise group will undergo hand grip exercise for 30 minutes a day, 5 days a week for a total of 12 weeks. To activate the ulnar nerve innervated muscles, the exercise will be done using an electronic hand grip device with adjustable resistance individualized to the strength of each participant.
Arm Title
Control group
Arm Type
Experimental
Arm Description
Participants will carry out a stretch exercise routine that is not known to have any effect on nerve regeneration.
Intervention Type
Other
Intervention Name(s)
Exercise group
Intervention Description
Along with nerve transfer surgery, individuals in the exercise group will undergo handgrip exercise for 30 minutes a day, 5 days a week for a total of 12 weeks.
Primary Outcome Measure Information:
Title
Motor nerve conduction study
Description
compound muscle action potential of the biceps muscle. Range: 0-7 mV. Higher scores signify better nerve regeneration
Time Frame
Baseline, 3, 6 and 9 months post surgery
Secondary Outcome Measure Information:
Title
magnetic resonance imaging (MRI)
Description
muscle bulk of the biceps. Measure in cubic cm. Higher score signifies better nerve regeneration.
Time Frame
Baseline, 3, 6 and 9 months post surgery
Title
dual energy x-rays absorptiometry (DEXA)
Description
bone density - humerus (g/sq. m). Higher scores denote better outcome
Time Frame
Baseline, 3, 6 and 9 months post surgery
Title
quantitative force measurement for elbow flexion using dynamometer DASH Questionnaire
Description
to assess impairment (N). Higher scores denote better outcome
Time Frame
Baseline, 3, 6 and 9 months post surgery
Title
Canadian Occupational Performance Measure (COPM)
Description
to assess handicap and participation (Range 1-5). Higher scores denote better outcome
Time Frame
Baseline, 3, 6 and 9 months post surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adults age 18-60 electrodiagnostically confirmed brachial plexus injury affecting the musculocutaneous nerve able to consent for participation. Exclusion Criteria: • individuals with additional neurological or musculoskeletal conditions that would affect elbow and hand function
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ming Chan
Phone
780-492-9343
Email
ming.chan@ualberta.ca
Facility Information:
Facility Name
University of Alberta
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2C9
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ming Chan
Phone
780-492-9343
Email
ming.chan@ualberta.ca

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Exercise Training for Brachial Plexus Injury Following Nerve Transfer

We'll reach out to this number within 24 hrs